Responding to Higher-Than-Expected Infant Mortality Rates from Respiratory Syncytial Virus (RSV): Improving Treatment and Reporting Strategies
Open Access
- 1 January 2023
- journal article
- review article
- Published by Taylor & Francis in Infection and Drug Resistance
- Vol. ume 16, 595-605
Abstract
Respiratory syncytial virus (RSV) has a major role in respiratory infections in young infants around the world. However, substantial progress has been made in recent years in the field of RSV. A wide variety of observational studies and clinical trials published in the past decade provide a thorough idea of the health and economic burden of RSV disease in the developing world. In this review, we discuss the impact of RSV burden of disease, major gaps in disease estimations, and challenges in generating new therapeutic options and an immune response against the virus, and briefly describe next generation technologies that are being evaluated.Keywords
This publication has 84 references indexed in Scilit:
- Respiratory Syncytial Virus Persistence in Macrophages Alters the Profile of Cellular Gene ExpressionViruses, 2012
- Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000The Lancet, 2012
- Neonatal outcomes after influenza immunization during pregnancy: a randomized controlled trialCanadian Medical Association Journal, 2012
- Respiratory Syncytial Virus Glycoprotein G Interacts with DC-SIGN and L-SIGN To Activate ERK1 and ERK2Journal of Virology, 2012
- Autopsy acceptance rate and reasons for decline in Mulago Hospital, Kampala, UgandaTropical Medicine & International Health, 2011
- Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysisThe Lancet, 2010
- Clinico-Pathological Discrepancies in the Diagnosis of Causes of Maternal Death in Sub-Saharan Africa: Retrospective AnalysisPLOS Medicine, 2009
- The Secreted Form of Respiratory Syncytial Virus G Glycoprotein Helps the Virus Evade Antibody-Mediated Restriction of Replication by Acting as an Antigen Decoy and through Effects on Fc Receptor-Bearing LeukocytesJournal of Virology, 2008
- Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus diseaseNature Medicine, 2008
- Respiratory syncytial virus impairs T cell activation by preventing synapse assembly with dendritic cellsProceedings of the National Academy of Sciences, 2008